![](/img/cover-not-exists.png)
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients
Taher, Ali T., Porter, John B., Viprakasit, Vip, Kattamis, Antonis, Chuncharunee, Suporn, Sutcharitchan, Pranee, Siritanaratkul, Noppadol, Galanello, Renzo, Karakas, Zeynep, Lawniczek, Tomasz, Habr, DVolume:
88
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.23445
Date:
June, 2013
File:
PDF, 268 KB
english, 2013